Recommendations for Screening, Testing, and Management of Blood Donors and Blood and Blood Components Based on Screening Tests for Syphilis: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 2, 2020
January 20, 2021
55e82ed9-047c-4235-9442-7dc1d1a9a4d0
Related Documents
Human Gene Therapy for Rare Diseases: Guidance for Industry
Guidance DocumentJanuary 28, 2020Center for Biologics Evaluation and Research
Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion: Guidance for Industry
Guidance DocumentDecember 17, 2020Center for Biologics Evaluation and Research
Human Gene Therapy for Hemophilia: Guidance for Industry
Guidance DocumentJanuary 28, 2020Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.